Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells.

Nawata J, Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Baron B, Akada J, Suenaga S, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2014 Sep;34(9):4807-11.

PMID:
25202061
2.

Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.

Suenaga S, Kuramitsu Y, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2014 Jan;34(1):141-6.

PMID:
24403454
3.
4.

CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells.

Kuhara K, Tokuda K, Kitagawa T, Baron B, Tokunaga M, Harada K, Terasaki M, Uehara O, Ohta T, Takai R, Hamada JI, Kobayashi M, Shimo T, Nagayasu H, Kuramitsu Y.

Anticancer Res. 2018 Nov;38(11):6107-6111. doi: 10.21873/anticanres.12961.

PMID:
30396925
5.

MicroRNA signature in the chemoprevention of functionally-enriched stem and progenitor pools (FESPP) by Active Hexose Correlated Compound (AHCC).

Graham √ČA, Mallet JF, Jambi M, Nishioka H, Homma K, Matar C.

Cancer Biol Ther. 2017 Oct 3;18(10):765-774. doi: 10.1080/15384047.2017.1373211. Epub 2017 Sep 8.

6.

Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.

Kuramitsu Y, Suenaga S, Wang Y, Tokuda K, Kitagawa T, Tanaka T, Akada J, Maehara S, Maehara Y, Nakamura K.

Anticancer Res. 2013 Aug;33(8):3133-6.

PMID:
23898070
7.

Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling.

Sun L, Cao J, Chen K, Cheng L, Zhou C, Yan B, Qian W, Li J, Duan W, Ma J, Qi D, Wu E, Wang Z, Liu Q, Ma Q, Xu Q.

Int J Oncol. 2019 Jan;54(1):98-110. doi: 10.3892/ijo.2018.4604. Epub 2018 Oct 24.

8.

High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.

Kuramitsu Y, Wang Y, Kitagawa T, Tokuda K, Akada J, Tokunaga M, Nakamura K.

Anticancer Res. 2015 Jul;35(7):3861-5.

PMID:
26124331
9.

Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.

Suenaga S, Kuramitsu Y, Wang Y, Baron B, Kitagawa T, Akada J, Tokuda K, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2013 Nov;33(11):4821-6.

PMID:
24222118
10.

Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells.

Shimada T, Nanimoto Y, Baron B, Kitagawa T, Tokuda K, Kuramitsu Y.

In Vivo. 2018 Jul-Aug;32(4):759-763. doi: 10.21873/invivo.11305.

11.

KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.

Taba K, Kuramitsu Y, Ryozawa S, Yoshida K, Tanaka T, Mori-Iwamoto S, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Chemotherapy. 2011;57(1):12-6. doi: 10.1159/000321019. Epub 2010 Dec 3.

PMID:
21124027
12.

MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis.

Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y.

PLoS One. 2011 Jan 27;6(1):e16617. doi: 10.1371/journal.pone.0016617.

13.

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H.

J Exp Ther Oncol. 2009;8(1):43-51.

PMID:
19827270
14.

Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.

Liu H, Du L, Wen Z, Yang Y, Li J, Dong Z, Zheng G, Wang L, Zhang X, Wang C.

Int J Mol Med. 2013 Jul;32(1):59-66. doi: 10.3892/ijmm.2013.1354. Epub 2013 Apr 19.

PMID:
23599173
15.

Inflammation-Related Tumor Progression in Murine Fibrosarcoma Exhibited Over-expression of Sex-determining Region Y-box 2 (Sox2) Compared to Parental Regressor Cells.

Kuramitsu Y, Tanaka I, Wang Y, Okada F, Tokuda K, Kitagawa T, Akada J, Nakamura K.

Anticancer Res. 2015 Jun;35(6):3217-21.

PMID:
26026081
16.

Sex-determining region of Y chromosome-related high-mobility-group box 2 in malignant tumors: current opinions and anticancer therapy.

Cao SG, Ming ZJ, Zhang YP, Yang SY.

Chin Med J (Engl). 2015 Feb 5;128(3):384-9. doi: 10.4103/0366-6999.150112. Review.

17.

SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity.

Nakatsugawa M, Takahashi A, Hirohashi Y, Torigoe T, Inoda S, Murase M, Asanuma H, Tamura Y, Morita R, Michifuri Y, Kondo T, Hasegawa T, Takahashi H, Sato N.

Lab Invest. 2011 Dec;91(12):1796-804. doi: 10.1038/labinvest.2011.140. Epub 2011 Sep 19.

18.

Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.

Kuramitsu Y, Taba K, Ryozawa S, Yoshida K, Zhang X, Tanaka T, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2010 Sep;30(9):3367-72.

PMID:
20944110
19.

Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells.

Taba K, Kuramitsu Y, Ryozawa S, Yoshida K, Tanaka T, Maehara S, Maehara Y, Sakaida I, Nakamura K.

Anticancer Res. 2010 Jul;30(7):2539-43.

PMID:
20682980
20.

Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.

Ikushima H, Todo T, Ino Y, Takahashi M, Saito N, Miyazawa K, Miyazono K.

J Biol Chem. 2011 Dec 2;286(48):41434-41. doi: 10.1074/jbc.M111.300863. Epub 2011 Oct 10.

Supplemental Content

Support Center